<DOC>
	<DOCNO>NCT01771042</DOCNO>
	<brief_summary>Elevated subconscious nervous system activity characteristic obese state contributes importantly risk heart disease diabetes . This project compare sympathetic nervous system activity function group obese person differ level sugar tolerance ( normal , impaired type 2 diabetic ) . Inter-relationships insulin action , blood pressure , heart kidney function determine 4-month weight loss 3-month weight loss maintenance program . It hypothesize transition normal sugar tolerance impair sugar tolerance type 2 diabetes accompany escalate sympathetic nervous system dysfunction . Furthermore , weight loss favorably improve sympathetic function , great benefit occur subject insulin resistant high blood insulin concentration .</brief_summary>
	<brief_title>The Effects Weight Loss Neuroadrenergic Function</brief_title>
	<detailed_description>The twin epidemic obesity diabetes represent major public health problem worldwide . There grow body evidence suggest autonomic dysfunction , comprise elevate sympathetic nervous system ( SNS ) activity blunt sympathetic neural responsiveness play role pathogenesis target organ complication obesity diabetes . The propose project undertake detailed comparative analysis neuroadrenergic function along diabetes continuum , inter-relationship insulin sensitivity secretion , target organ function , benefit active weight loss weight loss maintenance within different stratum metabolic risk .</detailed_description>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<criteria>Men postmenopausal woman ( n=120 ) , untreated , weightstable , nonsmoking , aged 4565 year , BMI 2745 kg/m2 , recruit . Glucose tolerance status determine 75g oral glucose tolerance test ( OGTT ) , use WHO criterion ( 53 ) : normal glucose tolerance , fast plasma glucose &lt; 7.0 mmol/L 2h plasma glucose &lt; 7.8 mmol/L ; IGT , fast plasma glucose &lt; 7.0 mmol/L 2h plasma glucose &gt; 7.8 &lt; 11.1 mmol/L ; T2D , fast plasma glucose &gt; 7.0 mmol/L 2h plasma glucose &gt; 11.1 mmol/L . Hyperinsulinemia define insulin area curve OGTT &gt; 8000 mU/L ∙ min1 hypoinsulinemia &lt; 8000 mU/L ∙ min1 . Prior history cardiovascular disease ( previous myocardial infarction , angina , stroke , heart failure , secondary hypertension ) , renal ( serum creatinine &gt; 0.12 mmol/L estimate GFR &lt; 60 ml/min/1.73 m2 ) hepatic disease disease may affect measure parameter ( e.g . thyroid disease ) ; severe hypertension ; history surgical weight loss ; CPAP therapy ; &gt; 4 alcoholic drinks/day . T2D individual moderate hyperglycemia ( HbA1c &gt; 9 % ) exclude hypoglycaemic pharmacotherapy may institute ( 54 ) . Participants seek newspaper advertising poster display primary health care centre ( General Practices ) . Newly diagnose T2D subject</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>weight loss</keyword>
	<keyword>metabolic syndrome</keyword>
	<keyword>sympathetic nervous system</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>glucose tolerance</keyword>
</DOC>